Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+96.6%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+96.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
7.6x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.13M | +33.6% |
| 2024 | $847000.00 | +33.0% |
| 2023 | $637000.00 | +327.5% |
| 2022 | $149000.00 | +3625.0% |
| 2021 | $4000.00 | - |
| 2020 | $0.00 | - |